Fexofenadine HCl API

Holiness Pharmaceutical is a trusted and leading supplier and exporter of Fexofenadine HCl API, delivering high-quality anti-allergic APIs to pharmaceutical companies across 40+ international markets. Fexofenadine HCl is a second-generation antihistamine widely used for allergic rhinitis and chronic idiopathic urticaria, positioning us as a reliable Fexofenadine HCl bulk API supplier from India.

Globally, Holiness Pharmaceutical is recognized among reputable Fexofenadine HCl API manufacturers, offering high assay purity, stringent impurity control, excellent stability, and consistent process performance suitable for oral solid and liquid formulations. Our expertise in non-sedating antihistamine APIs makes us a dependable Pharmaceutical API exporter.

Our API manufacturing facilities operate in strict compliance with international regulatory standards including:
➡ DCGI, WHO-GMP, US-FDA aligned, and cGMP guidelines,
ensuring validated synthesis routes, tight impurity profiling, moisture and stability control, and pharmacopeial compliance for Fexofenadine HCl API.

We export Fexofenadine HCl API from India to Asia, Africa, Europe, the Middle East, North America, South America, and CIS regions, supporting formulation manufacturers producing high-quality anti-allergic medicines. Holiness Pharmaceutical is widely trusted as a bulk Fexofenadine HCl API supplier.

Holiness Pharmaceutical is one of the leading producers of Active Pharmaceutical Ingredients (APIs) and Intermediates, delivering GMP-compliant manufacturing systems, consistent batch quality, and globally accepted regulatory documentation as a certified Pharmaceutical API exporter.

Holiness Pharmaceutical has established a strong presence in many countries including:
United States, Canada, United Kingdom, Germany, France, Netherlands, Italy, Spain, Australia, New Zealand, Slovakia, Estonia, Belarus, Ukraine, Iceland, Kazakhstan, Uzbekistan, Turkmenistan, Tajikistan, Kyrgyzstan, Georgia, Russia, Yemen, Saudi Arabia, UAE, Qatar, Kuwait, Oman, Bahrain, Turkey, Senegal, Ethiopia, Eswatini, Cameroon, Zambia, Mozambique, Angola, Zimbabwe, Malawi, Seychelles, South Africa, Nigeria, Kenya, Tanzania, Ghana, Egypt, Panama, Costa Rica, El Salvador, Mexico, Brazil, Argentina, Chile, Peru, Colombia, Afghanistan, Bhutan, Cambodia, Vietnam, Indonesia, Philippines, Malaysia, Thailand, South Korea, Japan, Paraguay, Bangladesh.